Marvel Biosciences Corp. (TSXV:MRVL)
Canada
· Delayed Price · Currency is CAD 0.145
+0.005 (3.57%)
At close: Mar 9, 2026
Marvel Biosciences Balance Sheet
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 0.63 | 0.13 | 0.35 | 0.56 | 0.59 | 2.39 | Upgrade
|
| Cash & Short-Term Investments | 0.63 | 0.13 | 0.35 | 0.56 | 0.59 | 2.39 | Upgrade
|
| Cash Growth | 660.66% | -62.73% | -37.88% | -6.17% | -75.21% | 964.52% | Upgrade
|
| Other Receivables | 0.03 | 0.17 | 0.12 | 0.08 | 0.06 | 0.06 | Upgrade
|
| Receivables | 0.03 | 0.17 | 0.12 | 0.08 | 0.06 | 0.06 | Upgrade
|
| Prepaid Expenses | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0.25 | 0.02 | Upgrade
|
| Total Current Assets | 0.68 | 0.33 | 0.49 | 0.67 | 0.91 | 2.47 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Total Assets | 0.68 | 0.33 | 0.49 | 0.67 | 0.91 | 2.47 | Upgrade
|
| Accounts Payable | 1.61 | 1.5 | 1.35 | 1.21 | 0.26 | 0 | Upgrade
|
| Accrued Expenses | 0.42 | 0.52 | 0.26 | 0.18 | 0.43 | 0.11 | Upgrade
|
| Current Portion of Long-Term Debt | 2.31 | 2.31 | 1.71 | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.03 | - | Upgrade
|
| Total Current Liabilities | 4.33 | 4.33 | 3.32 | 1.39 | 0.72 | 0.11 | Upgrade
|
| Long-Term Debt | - | - | - | 1 | - | - | Upgrade
|
| Total Liabilities | 4.33 | 4.33 | 3.32 | 2.39 | 0.72 | 0.11 | Upgrade
|
| Common Stock | 9.15 | 8.46 | 7.58 | 7.13 | 6.86 | 6.46 | Upgrade
|
| Additional Paid-In Capital | - | - | - | - | 0.12 | 0.1 | Upgrade
|
| Retained Earnings | -13.25 | -12.91 | -10.7 | -9.05 | -6.76 | -4.2 | Upgrade
|
| Comprehensive Income & Other | 0.45 | 0.44 | 0.29 | 0.2 | -0.03 | - | Upgrade
|
| Shareholders' Equity | -3.65 | -4.01 | -2.83 | -1.72 | 0.2 | 2.36 | Upgrade
|
| Total Liabilities & Equity | 0.68 | 0.33 | 0.49 | 0.67 | 0.91 | 2.47 | Upgrade
|
| Total Debt | 2.31 | 2.31 | 1.71 | 1 | - | - | Upgrade
|
| Net Cash (Debt) | -1.68 | -2.18 | -1.36 | -0.44 | 0.59 | 2.39 | Upgrade
|
| Net Cash Growth | - | - | - | - | -75.21% | 1087.94% | Upgrade
|
| Net Cash Per Share | -0.03 | -0.05 | -0.03 | -0.01 | 0.02 | 0.14 | Upgrade
|
| Filing Date Shares Outstanding | 58 | 58 | 44.79 | 39.79 | 39.79 | 32.59 | Upgrade
|
| Total Common Shares Outstanding | 57.5 | 52.95 | 44.79 | 39.79 | 37.09 | 32.59 | Upgrade
|
| Working Capital | -3.65 | -4.01 | -2.83 | -0.72 | 0.2 | 2.36 | Upgrade
|
| Book Value Per Share | -0.06 | -0.08 | -0.06 | -0.04 | 0.01 | 0.07 | Upgrade
|
| Tangible Book Value | -3.65 | -4.01 | -2.83 | -1.72 | 0.2 | 2.36 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | -0.08 | -0.06 | -0.04 | 0.01 | 0.07 | Upgrade
|
| Machinery | - | - | - | - | - | 0 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.